Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ENDO .0043 15-15 filed, let see what we get
Wow, look at those ask slaps coming in!!!! $$$ENDO$$$
ENDO .0054 just filed 15-15D these tend to run big
11-21-2013
https://www.prnewswire.com/news-releases/cannabis-science-inc-cbis-announces-broad-patent-licensing-agreement-with-endocan-corporation-endo-to-develop-the-cannabinoid-based-patent-n2010968-composition-for-the-treatment-of-neurobehavioral-disorders-for-over-the-c-232849231.html
10-29-2018
https://www.barrons.com/articles/PR-CO-20181029-908884
I like the way it looks like its going to shoot to the moon, but goes up a penny if that. Still looks go though, jmo.
I love your sig. Right on.
Really, I've been watching how it retraces itself daily.
Everything-is-quiet. It's Summertime. Nothing ever happens in Summertime!
I'm going to be very patient with you ENDO, very patient. You're going to payoff soon and I'm going to be very elated when you do. One thing though, can you give me some pr's to read while I wait?
I sold most of my shares for a small profit. Chart looks super bullish, but if they aren't going to release news/financials, it will be almost at the 2 year mark since we've heard from them. SEC loves suspending stocks if they go dark for 2 years. 2 years seems to be the lucky number. If they don't release something soon, this stock WILL get suspended. Good luck to you $ENDO
If they keep doing this I hope they never speak.
Endocan Corporation (ENDO)
0.023 +$.005 (27.78%)
Volume: 1,569,173
Really? I'm wondering what's going on that they're not talking about.
Idk, but the chart has been suggestive for a few weeks now. $ENDO
For what reason do you believe it's taking off? No pr's in about a year.
It's coming joker
With Federal Legalization in the works, I was hoping for a better day.
Nice candle today $ENDO
They have been very quiet, wish they posted a few more pr's. Someone likes something about them.
Judging only by the chart, I believe something is a brewin' here. $ENDO let's break .10
I've been quietly watching as it is slowly working its way up. Hoping something good is in the works.
Today's candlestick could be the sign that we move up very soon $ENDO
Do you imaging this will somehow become a reporting company with product and revenue ...lol...it's a Raymond c dabney stock scam ...I can't imagine it has any future like Cbis and CBCA and iIMCL ..... Just press releases and failire
Being patient here holding my shares
Have they released Phytiva yet? Or the help scented perfumes?
Lol It was $60 tap and the spread was enormous
$ENDO: Rockin pretty hard today
Now hitting $0.026
Nice mover
$ENDO
ENDO news...lol..what does that conference of real companies have to do with a dabney stock scam...I'm surprised they don't ask him to quit using the conference of real companies to further his failure ..scam or whatever it's called now ...they don't even file with the sec..and obviously have no sales unless they are pocketing the body wash cash...lmao...dabney ...what a clown !!!
Haven't payed much attention lately. When was the last time they filed financials? Also, what products?
Soon ...Dabney has been pocketing investors money from the sale of his products apparently ..that's not cool...or legal
This hasn't been suspended yet?
Do I need to explain it to you ??It's another Raymond dabney scam ... google the name along with sec .. you'll see he is a multiple time convicted stockvsczmmer ... remember when the iOS ljsr set this up years ago to sell cbis products ... lol... he defrauded every single believer ... d you understand that ... we will force this issue with the new administration to put this pos douchebag liar thief in prison !!!!
My Man come in Cbis and tell us it'a scam bla bla bla bla Loser
Followers
|
155
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9024
|
Created
|
09/04/01
|
Type
|
Free
|
Moderators |
About Endocan Corporation
The brand name Endocan(TM) was chosen by the Board as a direct reference to the endocannabinoid system of the human body. The endocannabinoid system is a group of neuromodulatory compounds and their receptors that are involved in a variety of fundamental physiological processes including pain-sensation, immune function, stress, sleep, mood, appetite, and memory. Cannabinoids from plants, including those found in the Cannabis genus, as well as those autonomously produced within living biological systems, work together in the operation of the endocannabinoid system. The modulation of this system is the basis for cannabinoid-based medical treatments to assist patients to improve their health and well-being.
Endocan Corporation, (FKA The X-Change Corporation) is currently developing new natural cannabinoid containing products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis, and hemp have been known and applied for thousands of years. With the aid of scientific research, Endocan Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.
"GOOD HEALTH! In an ever changing world the one thing that should be maintained is good health."
Endocan is the next stage of innovative cannabinoid-based solutions, with a focus on the health needs of people today. Globally, the diagnoses of critical ailments such as HIV/AIDS, cancer, autoimmune disease, high blood pressure, dementia, and more are arising. Despite scientific advances, we are facing a situation in which millions of people continue to be affected by life-threatening conditions with no truly effective means of treating them. The world needs smart science and research, strong leadership, and new products to respond to ever growing medical need.
Endocan utilizes the unique and potent benefits of cannabinoids, the natural compounds found in the Cannabis plants, from which cannabis and hemp are produced. Cannabinoid based products are potentially the ideal solution for many conditions and diseases.
Endocan strives to become known as one of the quintessential brands in the world, featuring multiple products, including cosmeceuticals and nutraceuticals. Cosmetics and nutrition are personal over the counter markets that continuously evolve with new formulations and products. The personal care market is estimated at $350 billion in 2012, with skin care growing approximately 7% over the next five years. The U.S. cosmeceuticals market is estimated at about $5-6 billion, while in the EU the market is worth between $3 and $5 billion. The Japanese is a market worth of about $6-8 billion.
Endocan, we believe, will capture a sizable portion of the market as Endocan becomes a household name. Endocan is poised to become known and flourish in the retail marketplace.
Endocan has something unique to offer with our formulation and innovative products and branding identity. Our formulations include natural, proprietary oil extracts to ensure the quality and effectiveness of the products.
Sales for Endocan's product lines are forecasted to grow into hundreds of millions of dollars upon realization of full global expansion and franchising opportunities.
There are over 525 natural components found in the Cannabis plant. Cannabinoids are believed to be at least 85 if not over 100 of these natural components. These components interact with specific receptors called “cannabinoid receptors.”
Two receptors have been found to date, called CB1 and CB2. The cannabinoids are separated into subclasses:
The cannabinoids mentioned most often are Tetrahydrocannabinols (THC) and Cannabidiols, for the simple reason that they are more frequently occurring in most strains and produce the most activity in the body. A substance that occurs naturally in the brain and binds to CB1 receptors was discovered in 1992 by Raphael Mechoulam’s team at the Hebrew University in Jerusalem. This substance is called “anandamide.” Other naturally occurring substances that bind to CB1 have been discovered since then. Together, they are called the “endogenous cannabinoid system” or the “endocannabinoid system.”
The cannabinoids most useful in combatting the world’s devastating illnesses are THC (delta-9 tetrahydrocannabinol) and CBD (cannabidiol), though other cannabinoids are beneficial as well. Major ailments, such as squamous and basal cell carcinomas, respond very positively to the topical application of oil extracted from the cannabis plant and containing high concentrations of THC. More about this process can be seen in our Patient Resource Center.
A major ingredient in our skincare products is hemp, which is a distant cousin to cannabis. Its main ingredient is the non-psychoactive cannabinoid called cannabidiol or CBD. Industrial hemp is characterized as being low in THC (delta-9 tetrahydrocannabinol) and high in CBD. CBD’s anti-cancer potential is currently being studied actively. It also has been shown to suppress inflammatory and neuropathic pain, exert anti-convulsant effects, and control other types of chronic pain, according to the National Center for Biotechnology Information. While CBD is important in treating certain ailments, the skin benefits most from the Omega-3 and Omega-6 essential fatty acids that are found in hemp.
The use of cannabis is thought to stretch back 4,000 years. It has been used as a medicine globally, including India, China, and the Middle East. In China, it was used to treat malaria, constipation, and rheumatism. There are even theories that cannabis use appears in the Old Testament of the Bible.
In the middle of the nineteenth century, doctors began to take an interest in it as a medicine, and it was a popular choice. Even Queen Victoria of England was given cannabis by her doctor to relieve period pains. Beginning in the early 20th century, cannabis began to be made illegal around the world, including North America and Europe.
The recreational use of cannabis has continued through today, and scientists and doctors have started studying the medicinal benefits of the plant as well. The first country to federally legalize cannabis for medicinal use was Canada in 2000. The first state in the U.S. was California in 1996. Twenty states and the District of Columbia have legalized medical cannabis in the United States and additional states are considering doing so as well.
Endocan develops products for critical ailments.
The number of diagnoses for various life-threatening diseases is rising every day. Endocan recognizes this global pandemic and is committed to with smart and sensible science.Endocan's product lines continue to mature toward critical care for people suffering from life threatening diseases like cancer and HIV. The Company's strategic research collaborations, including our strategic partners, Cannabis Science, Inc. and the medical cannabis dispensaries in legal state jurisdictions, will advance these cannabinoid-based breakthroughs in the rapidly expanding critical care market. Further, while chemotherapy and surgical treatment costs quickly rise into the hundreds of thousands of dollars per patient on an annual basis, safe, natural, and effective cannabinoid-based treatments for the same ailments are projected to cost less than ten thousand dollars per patient per annum.
Diagnoses of certain maladies are rising, and more diseases are constantly added to the medical canon. Many diseases have been classified as epidemics. The people on this planet are in dire need of something new. Endocan has identified 20 critical ailments that cannabinoids can treat and numerous skin afflictions as well. This section covers the 5 Why's and 1 How about these ailments:
Who can get them? What are they? When can a patient contract them? Where in the body do they appear, and what are the symptoms? Why do they show up? And lastly: How can cannabinoids make a difference?
Explore this section for this information, whether you are a patient, have a loved one with an illness, or are merely interested in cannabinoid science.
Endocan is dedicated to quality, respect for human life, and constant evaluation.
Respect for human life is a core value at Endocan. We believe that there are countless possibilities to be unleashed from the cornucopia of nature for good health and wellbeing. We use the latest science and technology to study these possibilities and make our products accessible to all. First, all Europe, the United States, and beyond.
Our employees are a central part of the company as well. We always take their needs into consideration. They are trained to comply with all laws and mandates. Our employees are held to high standards and rewarded for their work.
Please click on the document title to download.
Endocan Corporation 2013 Executive Summary Company Stock Symbol
XCHC - View Stock Quote
Share Structure
Common Stock
Authorized - 750,000,000
Issued - 26,746,504
Par Value - $0.001
Preferred Stock
Authorized - 100,000,000
Issued - NIL
Par Value - $0.001
Stock Transfer Agent
Signature Stock Transfer, Inc.
2632 Coachlight Court
Plano, TX 75093
Phone: (972) 612-4120
Email: signaturestock@aol.com
http://www.endocan.com/
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |